Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
Bristol-Myers Squibb
ImmuneSensor Therapeutics Inc.
Incyte Corporation
Incyte Corporation
Incyte Corporation
NRG Oncology
Incyte Corporation
Emory University
Sarcoma Oncology Research Center, LLC
Stanford University
Pfizer
Novartis
GlaxoSmithKline
Pfizer
Yale University
Pfizer
ADC Therapeutics S.A.
Pfizer
Eli Lilly and Company
Novartis
Rutgers, The State University of New Jersey
University of Florida
Hoffmann-La Roche
Genmab
Incyte Corporation
Nektar Therapeutics
Incyte Corporation
Duke University
Pfizer
Five Prime Therapeutics, Inc.
Incyte Corporation
Bristol-Myers Squibb
Gilead Sciences
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Eli Lilly and Company
Barbara Ann Karmanos Cancer Institute
Stanford University
Pfizer
Eli Lilly and Company
Stanford University
University of Kansas Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Fox Chase Cancer Center
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Bristol-Myers Squibb